Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 11, 2009, Pages 992-998

  Fukuyama, Satoru ^a   Nakano, Takako ^a   Matsumoto, Takafumi ^a   Oliver, Brian G G ^b   Burgess, Janette K ^b   Moriwaki, Atsushi ^a   Tanaka, Kentaro ^a,c   Kubo, Masato ^d   Hoshino, Tomoaki ^e   Tanaka, Hiroyuki ^f   McKenzie, Andrew N J ^g   Matsumoto, Koichiro ^a   Aizawa, Hisamichi ^e   Nakanishi, Yoichi ^a   Yoshimura, Akihiko ^c   Black, Judith L ^b   Inoue, Hiromasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF SYDNEY   (Australia)

^c KYUSHU UNIVERSITY   (Japan)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^g MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Allergy; Repressor molecule; Signal transducer and activator of transcription 6; Th2 cytokine

Indexed keywords

EOTAXIN; INTERLEUKIN 13; JANUS KINASE; STAT PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ASTHMA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-13; MICE; MYOCYTES, SMOOTH MUSCLE; STAT6 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH2 CELLS; UP-REGULATION;

EID: 66249104990     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200806-992OC     Document Type: Article

References (40)

1. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039. (Pubitemid 20336962)
2. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789-815. (Pubitemid 38680442)
3. Georas SN, Guo J, De Fanis U, Casolaro V. T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005;26:1119-1137. (Pubitemid 41829946)
4. Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 2000;113:2813-2819.
5. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003;4:1169-1176. (Pubitemid 37540685)
6. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007;7:454-465. (Pubitemid 46834848)
7. Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, et al. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med 2003;9:1047-1054. (Pubitemid 37021785)
8. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O'Shea JJ. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 2006;103:8137-8142. (Pubitemid 43801065)
9. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Yamauchi M, Himeno K, Kobayashi T, Yoshimura A. SOCS3 and STAT3 regulate TGF-beta production in CD4 helper T cell differentiation. J Exp Med 2006;203:1021-1031.
10. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-2263. (Pubitemid 29004075)
11. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261. (Pubitemid 29004074)
12. Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, Ikegami T, Aizawa H, Hara N. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003;167:50-56. (Pubitemid 36015917)
13. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939-948. (Pubitemid 28141667)
14. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, Homer RJ, Zhu Z, Rincon M, Mossman BT, Elias JA. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 2006;116:163-173. (Pubitemid 43121801)
15. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006;12:99-106.
16. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002;8:885-889.
17. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002;109:S121-S131.
18. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000;18:143-164. (Pubitemid 30365377)
19. Chan V, Burgess JK, Ratoff JC, O'Connor BJ, Greenough A, Lee TH, Hirst SJ. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006;174:379-385. (Pubitemid 44223117)
20. Inoue H, Fukuyama S, Kubo M, Yoshimura A, Oiiver BGG, Burgess JK, Black JL, Nakanishi Y. Pulmonary SOCS1 as a central endogenous inhibitor of allergic asthma. Keystone Symposia on Molecular and Cellular Biology - Allergy and Asthma; January 20-25, 2009; Keystone, Colorado.
21. Inoue H, Fukuyama S, Nakano T, Matsumoto T, Moriwaki A, Matsumoto K, Yoshimura A, Kubo M, Nakanishi Y. SOCS1 induced by IL-13 in airway structural cells controls allergic asthma [abstract]. Am J Respir Crit Care Med 2008:A62.
22. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999;98:609-616. (Pubitemid 29418952)
23. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002;17:583-591. (Pubitemid 35351504)
24. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998;8:339-342. (Pubitemid 28159120)
25. Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, Hanakawa Y, Yoshimura A, Ross J Jr, Chien KR. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 2001;108:1459-1467. (Pubitemid 33091983)
26. Egan PJ, Lawlor KE, Alexander WS, Wicks IP. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 2003;111:915-924. (Pubitemid 37074967)
27. Hebenstreit D, Luft P, Schmiedlechner A, Regl G, Frischauf AM, Aberger F, Duschl A, Horejs-Hoeck J. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6- binding motifs located upstream of the transcription initiation site. J Immunol 2003;171:5901-5907. (Pubitemid 37467207)
28. Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T, Kishimoto T. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma. J Immunol 2000;164:5833-5843. (Pubitemid 30389827)
29. Schluter G, Boinska D, Nieman-Seyde SC. Evidence for translational repression of the SOCS-1 major open reading frame by an upstream open reading frame. Biochem Biophys Res Commun 2000;268:255-261. (Pubitemid 30119608)
30. Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol 2005;42:295-303. (Pubitemid 39626761)
31. De Sanctis GT, Merchant M, Beier DR, Dredge RD, Grobholz JK, Martin TR, Lander ES, Drazen JM. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet 1995;11:150-154.
32. Corris PA, Dark JH. Aetiology of asthma: lessons from lung transplantation. Lancet 1993;341:1369-1371. (Pubitemid 23159985)
33. Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol 2006;117:1446-1454. (Pubitemid 43795756)
34. Burgess JK, Blake AE, Boustany S, Johnson PR, Armour CL, Black JL, Hunt NH, Hughes JM. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol 2005;115:302-308. (Pubitemid 40215093)
35. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474-477. (Pubitemid 32778219)
36. Roth M, Johnson PR, Borger P, Bihl MP, Rudiger JJ, King GG, Ge Q, Hostettler K, Burgess JK, Black JL, et al. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004;351:560-574. (Pubitemid 39025173)
37. Huang SK, Xiao HQ, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-2694.
38. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665. (Pubitemid 27213194)
39. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005;115:747-754. (Pubitemid 40322251)
40. Harada M, Nakashima K, Hirota T, Shimizu M, Doi S, Fujita K, Shirakawa T, Enomoto T, Yoshikawa M, Moriyama H, et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am J Respir Cell Mol Biol 2007;36:491-496. (Pubitemid 46623008)